or Try an Advanced Search...

    Technical Analysis for ACIU - AC Immune SA

    Grade Last Price % Change Price Change
    F 3.00 5.63% 0.16
    ACIU closed up 5.63 percent on Friday, November 1, 2024, on 85 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Flat
    Historical ACIU trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Earnings Movers Other 0.00%
    Oversold Stochastic Weakness 0.00%
    Below Lower BB Weakness 5.63%
    Gapped Down Weakness 5.63%
    Lower Bollinger Band Touch Weakness 5.63%
    Oversold Stochastic Weakness 5.63%
    NR7 Range Contraction 1.01%
    NR7-2 Range Contraction 1.01%
    Narrow Range Bar Range Contraction 1.01%
    Older End-of-Day Signals for ACIU ...

       Recent Intraday Alerts

    Alert Time
    Up 1 ATR about 16 hours ago
    60 Minute Opening Range Breakout about 16 hours ago
    Up 5% about 16 hours ago
    Rose Above Previous Day's High about 16 hours ago
    60 Minute Opening Range Breakdown about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ACIU Chart by TradingView
    Basic chart:

    Profile

    AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimer’s and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinson's, and focuses on producing therapeutic and diagnostic product candidates, using SupraAntigen and Morphomer technology platforms. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn, among others.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biology Organ Systems Imaging Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Dementia Psychiatric Diagnosis Glaucoma Degenerative Disease Neurodegeneration Imaging Agent Amyloid Beta Company's Pipeline

    Is ACIU a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 28 AC Immune SA (NASDAQ:ACIU) stock most popular amongst individual investors who own 32%, while private equity firms hold 29%
    Sep 23 Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Sep 17 AC Immune receives second milestone payment under Janssen agreement
    Sep 17 AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease
    Aug 29 FDA grants fast track designation to Life Molecular Imaging’s tau PET diagnostic
    Aug 28 AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions
    Aug 22 The past three years for AC Immune (NASDAQ:ACIU) investors has not been profitable
    Jul 31 AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024
    Jul 26 AC Immune: Takeda Partnership Brings Funds To Drive Pipeline Forward
    Jul 25 AC Immune wins FDA fast track for Alzheimer’s vaccine
    See more ACIU news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.14
    52 Week Low 2.25
    Average Volume 85,964
    200-Day Moving Average 3.37
    50-Day Moving Average 3.27
    20-Day Moving Average 3.14
    10-Day Moving Average 3.01
    Average True Range 0.16
    RSI (14) 40.12
    ADX 17.76
    +DI 11.63
    -DI 22.30
    Chandelier Exit (Long, 3 ATRs) 3.05
    Chandelier Exit (Short, 3 ATRs) 3.28
    Upper Bollinger Bands 3.44
    Lower Bollinger Band 2.83
    Percent B (%b) 0.27
    BandWidth 19.40
    MACD Line -0.12
    MACD Signal Line -0.11
    MACD Histogram -0.0169
    Fundamentals Value
    Market Cap 296.4 Million
    Num Shares 98.8 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -3.19
    Price-to-Sales 284765.75
    Price-to-Book 1.86
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.23
    Resistance 3 (R3) 3.20 3.10 3.19
    Resistance 2 (R2) 3.10 3.04 3.11 3.17
    Resistance 1 (R1) 3.05 3.01 3.08 3.08 3.16
    Pivot Point 2.95 2.95 2.96 2.96 2.95
    Support 1 (S1) 2.90 2.89 2.93 2.93 2.84
    Support 2 (S2) 2.80 2.86 2.81 2.83
    Support 3 (S3) 2.75 2.80 2.81
    Support 4 (S4) 2.78